{"ORPHApacket":[{"ORPHApacketID":"247698","date":"2019-12-06 01:03:17","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"247698","Name":[{"lang":"en","label":"Multiple endocrine neoplasia type 2A"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_247698","DisorderType":[{"Name":[{"lang":"en","label":"Clinical subtype"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377796"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Catecholamine-producing tumor"}],"ORPHA":"717","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_717"},{"Name":[{"lang":"en","label":"Multiple endocrine neoplasia type 2"}],"ORPHA":"653","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_653"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Multiple endocrine neoplasia 2A (MEN2A) syndrome is a form of MEN2 (see this term) characterized by medullary thyroid carcinoma (MTC; see this term) in combination with pheochromocytoma (see this term) and primary mild hyperparathyroidism resulting from hyperplasia or adenoma of the parathyroid cells."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"171400","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal dominant"}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"MEN2A"},{"lang":"en","label":"PTC syndrome"},{"lang":"en","label":"Sipple syndrome"}]}]}]}